KEAP1 and adenoma: Accumulated SQSTM1/p62 then traps Keap1, a negative regulator of NRF2, and releases NRF2 from Keap1-mediated regulation, leading to the NRF2 signaling activation and enhancing adenoma formation in the liver [84,95,96,97].